Three biotech stocks are making their mark, hovering around the top of the IBD 50 list, and even held all three top slots at one time over the past week. Eight biotech stocks made the list but Travere Therapeutics (TVTX), Eton Pharmaceuticals (ETON) and Kiniksa (KNSA) stood out. All three names are at or near profitability and their stocks gapped…
Extract — continue reading at the source.
Related stories
JPMorgan Chase CEO Jamie Dimon Dropped a 9-Word Warning: "Margin Debt Is the Highest It Has Ever Been." Should Investors Be Worried?
Warren Buffett’s Berkshire makes backdoor SpaceX play
AI’s Absurd Spending Boom? Hyperscalers Are Spending 102% of Cloud Revenue on Capex
Billionaire Stephen Mandel Just Loaded Up on This Incredible Artificial Intelligence (AI) Stock Up Nearly 200% in 2026
Oppenheimer has a blunt Nvidia stock message ahead of earnings
The S&P 500 Is Near an All-Time High. Here's What History Says Investors Should Do.